Attovia Therapeutics
Attovia is seeking a senior-level leader responsible for the global manufacture of biologics, overseeing the entire process from discovery through clinical development to commercial phases. The role involves ensuring GMP manufacturing, collaborating with global partners, and driving process improvements to support groundbreaking biotherapeutics.
Headquarters
San Carlos, California, United States
Company Size
11-50 employees
Founded
2023
Attovia is a clinical-stage biotech developing first-in-class multispecific biologics to address high unmet need in immune‑mediated diseases and inflammation. Using its proprietary ATTOBODY platform, the company designs precision multispecific therapies that engage multiple aspects of disease biology where current treatments fall short. Attovia’s approach aims to deliver novel, targeted options for patients who are undertreated or lack effective therapies today.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Attovia Therapeutics.
Attovia Therapeutics didn’t post a salary, so this is our estimate from similar listings.
91% below the average for this role
Director, CMC Product Development – Biologics
Beeline Medicines
Sr. Director, Regulatory CMC
Genetix Biotherapeutics
CMC Specialist with GMP Biologics Manufacturing Expertise
ASTARPRD
Strategy Lead, CMC Mature, Regulatory Affairs
GSK plc
Director, Global Regulatory Affairs - Chemistry, Manufacturing and Controls (CMC), Platform Innovation - Biologics
Eli Lilly and Company
Senior Director Regulatory Affairs, CMC
BeOne Medicines